Skip to content

APOTHEKERS BEKE-DEBUSSCHERE

Active
Private limited companyfounded 2003active for 22 yearsHoogstraat 43, 8540 Deerlijk, BelgiumKBO/BCE: BE 0862.165.296

From the official registers: KBO 21 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEKERS BEKE-DEBUSSCHERE has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €898,858 and a net result of €40,162. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 63% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisFollow ReportCompare
APOTHEKERS BEKE-DEBUSSCHEREActiveChecked score 83/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 12-12-2003 Normal situation
Legal form
Private limited company
Registered office
Hoogstraat 43, 8540 Deerlijk
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment units
2.230.535.982 8540 Deerlijk, since 12-12-2003
2.369.495.610 8540 Deerlijk, since 01-02-2025
Financial year end
30 June
Peppol
Reachable since 30-10-2023
Company details

Who decides

Board
Board & ownership

How it is doing

83 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Annual accounts to 30-06-2025
Gross margin
€421,097
▼ 32.5%
Turnover
≈ €1.5m
estimated
Profit
€40,162
▼ 77.8%
Equity
€898,858
▼ 11.2%
Total assets
€1.8m
▼ 0.7%
Staff
2.5 FTE
▼ 16.7%
2025 accounts 1 day early
Filed on 30-01-2026PDF
Financials
Why 83raises riskLiquidity: current ratio 1.58, cash €38,245, halvedlowers riskFounded in 2003Size: 2.5 FTE, total assets €1.8mEquity €898,858 (48.6% of total assets)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 43% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 74-5
equity 48.6% of total assets
Liquidity 40-12
short-term debt 30.3% · cash 2.1%
Profitability 63-18
return on assets 2.2%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.4%▲ +0.2 percentage points vs 12-2024 02-2025: 0.1%▼ -0.3 percentage points vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025lowest value 04-2025: 0.1%● unchanged vs 03-2025lowest value 05-2025: 0.1%● unchanged vs 04-2025lowest value 06-2025: 0.1%● unchanged vs 05-2025lowest value 07-2025: 0.1%● unchanged vs 06-2025lowest value 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: 0.2%▲ +0.1 percentage points vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.3%▲ +0.1 percentage points vs 12-2025 02-2026: 0.5%▲ +0.2 percentage points vs 01-2026highest value 03-2026: 0.3%▼ -0.2 percentage points vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.4%▲ +0.1 percentage points vs 09-2026
Credit of up to €70,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.58, compared with 2.16 in 2024, above the usual 1.5; short-term debt: 30.3% and cash: 2.1% of total assets), but 51.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 63% on solvency, 38% on liquidity, 45% on profitability and 25% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 1.58, cash €38,245, halved
NBB · annual accounts
lowers risk · Founded in 2003
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: 2.5 FTE, total assets €1.8m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €898,858 (48.6% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 day early
2024
1 day early
2023
on the day
2022
1 day early
2021
2 days early
2020
2 days early
2019
4 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 30 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end01-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Caution: Result fell in 2025from €180,925 to €40,162 ▼ 77.8% View
  • Positive: Among the best 15% on equitysector median €237,045 · 12,747 companies €898,858 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €40,162 7 years View

Documents

Annual accounts at the NBB

All 21 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about APOTHEKERS BEKE-DEBUSSCHERE

What is the company number of APOTHEKERS BEKE-DEBUSSCHERE?
0862.165.296. In Belgium the VAT number is the company number with BE in front: BE 0862.165.296.
Where is APOTHEKERS BEKE-DEBUSSCHERE based?
The registered office is at Hoogstraat 43, 8540 Deerlijk.Company details
What does APOTHEKERS BEKE-DEBUSSCHERE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEKERS BEKE-DEBUSSCHERE?
Private limited company (BV).
When was APOTHEKERS BEKE-DEBUSSCHERE founded?
On 12-12-2003.
Is APOTHEKERS BEKE-DEBUSSCHERE still active?
Yes, APOTHEKERS BEKE-DEBUSSCHERE is an active enterprise in the KBO register.
How many employees does APOTHEKERS BEKE-DEBUSSCHERE have?
On average 2.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEKERS BEKE-DEBUSSCHERE?
≈ €1.5m in financial year 2025. Estimated from the gross margin of €421,097: probably between €1.2m and €2.5m, based on 47 comparable companies, NACE 477.
Is APOTHEKERS BEKE-DEBUSSCHERE profitable?
In financial year 2025, APOTHEKERS BEKE-DEBUSSCHERE made a profit of €40,162.
Where can I find the annual accounts of APOTHEKERS BEKE-DEBUSSCHERE?
APOTHEKERS BEKE-DEBUSSCHERE filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of APOTHEKERS BEKE-DEBUSSCHERE due?
By 31-01-2027, for financial year 2026.Timeline

Companies related to APOTHEKERS BEKE-DEBUSSCHERE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure